Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 4/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104404 | 1.00 | SMN1; SMN2 (0.54) | SMN1; SMN2POLBTDP1ANPEPKMT2A | |
| SCHEMBL6965546 | 0.86 | FFAR1 (0.50) | SMN1; SMN2POLBANPEPKMT2ACYP2C9 | |
| SCHEMBL284828 | 0.83 | KMT2A (0.46) | SMN1; SMN2TDP1ANPEPKMT2ACYP2C9 | |
| SCHEMBL2765505 | 0.83 | KMT2A (0.46) | SMN1; SMN2TDP1ANPEPKMT2ACYP2C9 | |
| SCHEMBL3554163 | 0.83 | KMT2A (0.46) | SMN1; SMN2TDP1ANPEPKMT2ACYP2C9 | |
| SCHEMBL288753 | 0.83 | GABBR2 (0.59) | SMN1; SMN2KMT2ACYP2C19CYP2D6GABBR2 | |
| SCHEMBL123765 | 0.83 | GABBR2 (0.59) | SMN1; SMN2KMT2ACYP2C19CYP2D6GABBR2 | |
| SCHEMBL59840 | 0.83 | GABBR2 (0.59) | SMN1; SMN2KMT2ACYP2C19CYP2D6GABBR2 | |
| SCHEMBL1138613 | 0.82 | FFAR1 (0.50) | SMN1; SMN2POLBANPEPKMT2ACYP2C9 | |
| SCHEMBL2764337 | 0.82 | FFAR1 (0.49) | SMN1; SMN2ANPEPKMT2ACYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105694914-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105694913-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105647181-A | Composition for flexible substrate and flexible substrate | 奇美实业股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-105602580-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-05-25 | — | — | CN | disclosed |
| CN-105567258-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-105567257-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-105482830-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-04-13 | — | — | CN | disclosed |
| CN-105462598-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORP | 2016-04-06 | — | — | CN | disclosed |
| CN-105316004-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-02-10 | — | — | CN | disclosed |
| CN-105295958-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-02-03 | — | — | CN | disclosed |
| CN-105273724-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-01-27 | — | — | CN | disclosed |
| CN-103865548-B | Liquid crystal alignment agent and application thereof | CHI MEI CORP. (CN) | 2015-12-30 | — | — | CN | disclosed |
| CN-104130784-B | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP. (CN) | 2015-12-30 | — | — | CN | disclosed |
| CN-103571500-B | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP. (CN) | 2015-12-23 | — | — | CN | disclosed |
| CN-105087020-A | Liquid crystal alignment agent and application thereof | CHI MEI CORP | 2015-11-25 | — | — | CN | disclosed |
| CN-105087019-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2015-11-25 | — | — | CN | disclosed |
| CN-105038818-A | Liquid crystal alignment agent and application thereof | CHI MEI CORP | 2015-11-11 | — | — | CN | disclosed |
| US-20110195993-A1 | PPAR AGONIST COMPOUNDS, PREPARATION AND USES | GENFIT (FR) | 2011-08-11 | — | — | US | disclosed |
| US-20030162799-A1 | Carbocyclic oxo, carboxy amines such as 3-(4-(3,5-Dichloro-4-pyridylcarboxamido)phenyl)-2-(2-propylamino-3,4 -dioxocyclobut-1-enyl)amino)propanoic acid, used as integrin antagonists; antiinflammatory agents | CELLTECH R&D LIMITED (GB) | 2003-08-28 | — | — | US | disclosed |
| US-6518283-B1 | To modify integrin function in such a way as to beneficially modulate cell adhesion | CELLTECH R&D LIMITED (GB) | 2003-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195993-A1 | PPAR AGONIST COMPOUNDS, PREPARATION AND USES | PPARD, PPARA, PPARG | SMN1; SMN2 4689/4885POLB 2900/4885TDP1 4011/4885 |
| US-20030162799-A1 | Carbocyclic oxo, carboxy amines such as 3-(4-(3,5-Dichloro-4-pyridylcarboxamido)phenyl)-2-(2-propylamino-3,4 -dioxocyclobut-1-enyl)amino)propanoic acid, used as integrin antagonists; antiinflammatory agents | ICAM1, VCAM1, CCR1 | SMN1; SMN2 2700/4885POLB 1466/4885TDP1 3793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.